Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Peggy Stolt-Bergner is active.

Publication


Featured researches published by Peggy Stolt-Bergner.


Nature Structural & Molecular Biology | 2011

Structural adaptation of the plant protease Deg1 to repair photosystem II during light exposure

Juliane Kley; Bastian Schmidt; Boril Boyanov; Peggy Stolt-Bergner; Rebecca Kirk; Michael Ehrmann; Ronit Rimon Knopf; Leah Naveh; Zach Adam; Tim Clausen

Deg1 is a chloroplastic protease involved in maintaining the photosynthetic machinery. Structural and biochemical analyses reveal that the inactive Deg1 monomer is transformed into the proteolytically active hexamer at acidic pH. The change in pH is sensed by His244, which upon protonation, repositions a specific helix to trigger oligomerization. This system ensures selective activation of Deg1 during daylight, when acidification of the thylakoid lumen occurs and photosynthetic proteins are damaged.


Journal of Biological Chemistry | 2010

Mutations in the carboxyl-terminal SEC24 binding motif of the serotonin transporter impair folding of the transporter.

Ali El-Kasaby; Herwig Just; Elisabeth Malle; Peggy Stolt-Bergner; Harald H. Sitte; Michael Freissmuth; Oliver Kudlacek

The serotonin transporter (SERT) is a member of the SLC6 family of solute carriers. SERT plays a crucial role in synaptic neurotransmission by retrieving released serotonin. The intracellular carboxyl terminus of various neurotransmitter transporters has been shown to be important for the correct delivery of SLC6 family members to the cell surface. Here we studied the importance of the C terminus in trafficking and folding of human SERT. Serial truncations followed by mutagenesis identified sequence spots (PG601,602, RII607–609) within the C terminus relevant for export of SERT from the endoplasmic reticulum (ER). RI607,608 is homologous to the RL-motif that in other SLC6 family members provides a docking site for the COPII component Sec24D. The primary defect resulting from mutation at PG601,602 and RI607,608 was impaired folding, because mutated transporters failed to bind the inhibitor [3H]imipramine. In contrast, when retained in the ER (e.g. by dominant negative Sar1) the wild type transporter bound [3H]imipramine with an affinity comparable to that of the surface-expressed transporter. SERT-RI607,608AA and SERT-RII607–609AAA were partially rescued by treatment of cells with the nonspecific chemical chaperone DMSO or the specific pharmacochaperone ibogaine (which binds to the inward facing conformation of SERT) but not by other classes of ligands (inhibitors, substrates, amphetamines). These observations (i) demonstrate an hitherto unappreciated role of the C terminus in the folding of SERT, (ii) indicates that the folding trajectory proceeds via an inward facing intermediate, and (iii) suggest a model where the RI-motif plays a crucial role in preventing premature Sec24-recruitment and export of incorrectly folded transporters.


Current Biology | 2012

Spatiotemporal Regulation of Ipl1/Aurora Activity by Direct Cdk1 Phosphorylation

Tomasz Zimniak; Veronika Fitz; Hongwen Zhou; Fabienne Lampert; Susanne Opravil; Karl Mechtler; Peggy Stolt-Bergner; Stefan Westermann

Oscillating cyclin-dependent kinase 1 (Cdk1) activity is the major regulator of cell-cycle progression, whereas the Aurora B kinase, as part of the chromosome passenger complex (CPC), controls critical aspects of mitosis such as chromosome condensation and biorientation on the spindle. How these kinases mechanistically coordinate their important functions is only partially understood. Here, using budding yeast, we identify a regulatory mechanism by which the Cdk1 kinase Cdc28 directly controls the Aurora kinase Ipl1. We show that Cdk1 phosphorylates Ipl1 on two serine residues in the N-terminal domain, thereby suppressing its association with the microtubule plus-end tracking protein Bim1 until the onset of anaphase. Failure to phosphorylate Ipl1 leads to its premature targeting to the metaphase spindle and results in constitutive Bim1 phosphorylation, which is normally restricted to anaphase. Cells expressing an Ipl1-Sli15 complex that cannot be phosphorylated by Cdk1 display a severe growth defect. Our work shows that Ipl1/Aurora is not only the catalytic subunit of the CPC but also an important regulatory target that allows Cdk1 to coordinate chromosome biorientation with spindle morphogenesis.


Nature | 2018

An extracellular network of Arabidopsis leucine-rich repeat receptor kinases

Elwira Smakowska-Luzan; G. Adam Mott; Katarzyna Parys; Martin Stegmann; Timothy C Howton; Mehdi Layeghifard; Jana Neuhold; Anita Lehner; Jixiang Kong; Karin Grünwald; Natascha Weinberger; Santosh B. Satbhai; Dominik Mayer; Wolfgang Busch; Mathias Madalinski; Peggy Stolt-Bergner; Nicholas J. Provart; M. Shahid Mukhtar; Cyril Zipfel; Darrell Desveaux; David S. Guttman; Youssef Belkhadir

The cells of multicellular organisms receive extracellular signals using surface receptors. The extracellular domains (ECDs) of cell surface receptors function as interaction platforms, and as regulatory modules of receptor activation. Understanding how interactions between ECDs produce signal-competent receptor complexes is challenging because of their low biochemical tractability. In plants, the discovery of ECD interactions is complicated by the massive expansion of receptor families, which creates tremendous potential for changeover in receptor interactions. The largest of these families in Arabidopsis thaliana consists of 225 evolutionarily related leucine-rich repeat receptor kinases (LRR-RKs), which function in the sensing of microorganisms, cell expansion, stomata development and stem-cell maintenance. Although the principles that govern LRR-RK signalling activation are emerging, the systems-level organization of this family of proteins is unknown. Here, to address this, we investigated 40,000 potential ECD interactions using a sensitized high-throughput interaction assay, and produced an LRR-based cell surface interaction network (CSILRR) that consists of 567 interactions. To demonstrate the power of CSILRR for detecting biologically relevant interactions, we predicted and validated the functions of uncharacterized LRR-RKs in plant growth and immunity. In addition, we show that CSILRR operates as a unified regulatory network in which the LRR-RKs most crucial for its overall structure are required to prevent the aberrant signalling of receptors that are several network-steps away. Thus, plants have evolved LRR-RK networks to process extracellular signals into carefully balanced responses.


Journal of Biological Chemistry | 2011

Random Mutagenesis of the Prokaryotic Peptide Transporter YdgR Identifies Potential Periplasmic Gating Residues

Elisabeth Malle; Hongwen Zhou; Jana Neuhold; Bettina Spitzenberger; Freya Klepsch; Thomas Pollak; Oliver Bergner; Gerhard F. Ecker; Peggy Stolt-Bergner

The peptide transporter (PTR) family represents a group of proton-coupled secondary transporters responsible for bulk uptake of amino acids in the form of di- and tripeptides, an essential process employed across species ranging from bacteria to humans. To identify amino acids critical for peptide transport in a prokaryotic PTR member, we have screened a library of mutants of the Escherichia coli peptide transporter YdgR using a high-throughput substrate uptake assay. We have identified 35 single point mutations that result in a full or partial loss of transport activity. Additional analysis, including homology modeling based on the crystal structure of the Shewanella oneidensis peptide transporter PepTso, identifies Glu56 and Arg305 as potential periplasmic gating residues. In addition to providing new insights into transport by members of the PTR family, these mutants provide valuable tools for further study of the mechanism of peptide transport.


Journal of Structural Biology | 2018

Baculovirus-driven protein expression in insect cells: A benchmarking study

Peggy Stolt-Bergner; Christian Benda; Tim Bergbrede; Hüseyin Besir; Patrick H. N. Celie; Cindy Chang; David Drechsel; Ariane Fischer; Arie Geerlof; Barbara Giabbai; Joop van den Heuvel; Georg Huber; Wolfgang Knecht; Anita Lehner; Regis Lemaitre; Kristina Nordén; Gwynn Pardee; Ines Racke; Kim Remans; Astrid Sander; Judith Scholz; Magda Stadnik; Paola Storici; Daniel Weinbruch; Isabel Zaror; Linda H.L. Lua; Sabine Suppmann

Baculovirus-insect cell expression system has become one of the most widely used eukaryotic expression systems for heterologous protein production in many laboratories. The availability of robust insect cell lines, serum-free media, a range of vectors and commercially-packaged kits have supported the demand for maximizing the exploitation of the baculovirus-insect cell expression system. Naturally, this resulted in varied strategies adopted by different laboratories to optimize protein production. Most laboratories have preference in using either the E. coli transposition-based recombination bacmid technology (e.g. Bac-to-Bac®) or homologous recombination transfection within insect cells (e.g. flashBAC™). Limited data is presented in the literature to benchmark the protocols used for these baculovirus vectors to facilitate the selection of a system for optimal production of target proteins. Taking advantage of the Protein Production and Purification Partnership in Europe (P4EU) scientific network, a benchmarking initiative was designed to compare the diverse protocols established in thirteen individual laboratories. This benchmarking initiative compared the expression of four selected intracellular proteins (mouse Dicer-2, 204 kDa; human ABL1 wildtype, 126 kDa; human FMRP, 68 kDa; viral vNS1-H1, 76 kDa). Here, we present the expression and purification results on these proteins and highlight the significant differences in expression yields obtained using different commercially-packaged baculovirus vectors. The highest expression level for difficult-to-express intracellular protein candidates were observed with the EmBacY baculovirus vector system.


Scientific Reports | 2018

Multiplex mutagenesis of four clustered CrRLK1L with CRISPR/Cas9 exposes their growth regulatory roles in response to metal ions

Julia Richter; James Matthew Watson; Peter Stasnik; Monika Borowska; Jana Neuhold; Matthias Berger; Peggy Stolt-Bergner; Vera Schoft; Marie-Theres Hauser

Resolving functions of closely linked genes is challenging or nearly impossible with classical genetic tools. Four members of the Catharanthus roseus receptor-like kinase 1-like (CrRLK1L) family are clustered on Arabidopsis chromosome five. To resolve the potentially redundant functions of this subclass of CrRLK1Ls named MEDOS1 to 4 (MDS1 to 4), we generated a single CRISPR/Cas9 transformation vector using a Golden Gate based cloning system to target all four genes simultaneously. We introduce single mutations within and deletions between MDS genes as well as knock-outs of the whole 11 kb gene cluster. The large MDS cluster deletion was inherited in up to 25% of plants lacking the CRISPR/Cas9 construct in the T2 generation. In contrast to described phenotypes of already characterized CrRLK1L mutants, quadruple mds knock-outs were fully fertile, developed normal root hairs and trichomes and responded to pharmacological inhibition of cellulose biosynthesis similar to wildtype. Recently, we demonstrated the role of four CrRLK1L in growth adaptation to metal ion stress. Here we show the involvement of MDS genes in response to Ni2+ during hypocotyl elongation and to Cd2+ and Zn2+ during root growth. Our finding supports the model of an organ specific network of positively and negatively acting CrRLK1Ls.


Nature | 2018

Publisher Correction: An extracellular network of Arabidopsis leucine-rich repeat receptor kinases.

Elwira Smakowska-Luzan; G. Adam Mott; Katarzyna Parys; Martin Stegmann; Timothy C Howton; Mehdi Layeghifard; Jana Neuhold; Anita Lehner; Jixiang Kong; Karin Grünwald; Natascha Weinberger; Santosh B. Satbhai; Dominik Mayer; Wolfgang Busch; Mathias Madalinski; Peggy Stolt-Bergner; Nicholas J. Provart; M. Shahid Mukhtar; Cyril Zipfel; Darrell Desveaux; David S. Guttman; Youssef Belkhadir

In this Letter, an incorrect version of the Supplementary Information file was inadvertently used, which contained several errors. The details of references 59–65 were missing from the end of the Supplementary Discussion section on page 4. In addition, the section ‘Text 3. Y2H on ICD interactions’ incorrectly referred to ‘Extended Data Fig. 4d’ instead of ‘Extended Data Fig. 3d’ on page 3. Finally, the section ‘Text 4. Interaction network analysis’ incorrectly referred to ‘Fig. 1b and Extended Data Fig. 6’ instead of ‘Fig. 2b and Extended Data Fig. 7’ on page 3. These errors have all been corrected in the Supplementary Information.


BMC Clinical Pharmacology | 2012

Decrypting structural and functional changes in LeuTAa at atomic level employing LRET

Azmat Sohail; Simon Bulling; Peggy Stolt-Bergner; Oliver Kudlacek; Gerhard F. Ecker; Michael Freissmuth; Thomas Stockner; Harald H. Sitte; Walter Sandtner

Background Neurotransmitter:sodium symporters (NSS) are integral membrane proteins that mediate the reuptake of monoamine neurotransmitters previously released into the synaptic cleft. They are of pharmacological significance because they are the target of many clinically important drugs. LeuTAa, a leucine/alanine transporter is a bacterial homolog to NSS. Crystal structures of LeuTAa with open to outward, occluded and inward-facing states have already been resolved at high resolution. Hence, LeuTAa serves as a good paradigm for exploring the structurefunction relationship of NSS proteins.


BMC Pharmacology | 2011

LRET-based intramolecular distance measurements in LeuTAa

Azmat Sohail; Peggy Stolt-Bergner; Gerhard F. Ecker; Michael Freissmuth; Thomas Stockner; Harald H. Sitte; Walter Sandtner

Background LeuTAa is a bacterial orthologue of mammalian Solute Carrier Class 6 (SLC6) neurotransmitter transporters from Aquifex aeolicus which transports leucine and alanine. SLC6 transporters are of great pharmacological interests because of their crucial role in neurotransmitter clearance. These proteins are also targets of many clinically relevant drugs. The crystal structure of LeuTAa has been resolved at atomic resolution of ~1.5 A. Although LeuT has a low overall sequence identity of about 20–25% to SLC6 members, the grade of conservation reaches around 55% in functionally critical transmembrane domains 1, 3, 6 and 8. For this very reason we are using LeuTAa as a good structural paradigm to explore the structural/functional information about SLC6-family members.

Collaboration


Dive into the Peggy Stolt-Bergner's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jana Neuhold

Max F. Perutz Laboratories

View shared research outputs
Top Co-Authors

Avatar

Harald H. Sitte

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Michael Freissmuth

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Anita Lehner

Research Institute of Molecular Pathology

View shared research outputs
Top Co-Authors

Avatar

Azmat Sohail

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Walter Sandtner

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Hongwen Zhou

Research Institute of Molecular Pathology

View shared research outputs
Top Co-Authors

Avatar

Oliver Kudlacek

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Thomas Stockner

Medical University of Vienna

View shared research outputs
Researchain Logo
Decentralizing Knowledge